Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma

by Incorvaia, Lorena, Bronte, Giuseppe, Bazan, Viviana, Badalamenti, Giuseppe, Rizzo, Sergio, Pantuso, Gianni, Natoli, Clara, Russo, Antonio
Published in Oncotarget (2016)

One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients

by Badalamenti, Giuseppe, Incorvaia, Lorena, Messina, Carlo, Musso, Emmanuela, Casarin, Alessandra, Ricciardi, Maria Rita, De Luca, Ida, Bazan, Viviana, Russo, Antonio
Published in Support Care Cancer (2019)

Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy

by Badalamenti, Giuseppe, Incorvaia, Lorena, Messina, Carlo, Musso, Emmanuela, Casarin, Alessandra, Ricciardi, Maria Rita, De Luca, Ida, Bazan, Viviana, Russo, Antonio
Published in Support Care Cancer (2019)

Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1

by Badalamenti, Giuseppe, Barraco, Nadia, Incorvaia, Lorena, Galvano, Antonio, Fanale, Daniele, Cabibi, Daniela, Calò, Valentina, Currò, Giuseppe, Bazan, Viviana, Russo, Antonio
Published in J Oncol (2019)

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma

by Bian, Benjamin, Fanale, Daniele, Dusetti, Nelson, Roque, Julie, Pastor, Sonia, Chretien, Anne-Sophie, Incorvaia, Lorena, Russo, Antonio, Olive, Daniel, Iovanna, Juan
Published in Oncoimmunology (2019)

Recent Advances in Desmoid Tumor Therapy

by Napolitano, Andrea, Mazzocca, Alessandro, Spalato Ceruso, Mariella, Minelli, Alessandro, Baldo, Francesca, Badalamenti, Giuseppe, Silletta, Marianna, Santini, Daniele, Tonini, Giuseppe, Incorvaia, Lorena, Vincenzi, Bruno
Published in Cancers (Basel) (2020)

Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?

by Fanale, Daniele, Amodeo, Valeria, Bazan, Viviana, Insalaco, Lavinia, Incorvaia, Lorena, Barraco, Nadia, Castiglia, Marta, Rizzo, Sergio, Santini, Daniele, Giordano, Antonio, Castorina, Sergio, Russo, Antonio
Published in Oncotarget (2016)

Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway

by Massihnia, Daniela, Galvano, Antonio, Fanale, Daniele, Perez, Alessandro, Castiglia, Marta, Incorvaia, Lorena, Listì, Angela, Rizzo, Sergio, Cicero, Giuseppe, Bazan, Viviana, Castorina, Sergio, Russo, Antonio
Published in Oncotarget (2016)

“Back to a false normality”: new intriguing mechanisms of resistance to PARP inhibitors

by Incorvaia, Lorena, Passiglia, Francesc, Rizzo, Sergio, Galvano, Antonio, Listȶ, Angela, Barraco, Nadia, Maragliano, Rossella, Calò, Valentina, Natoli, Clara, Ciaccio, Marcello, Bazan, Viviana, Russo, Antonio
Published in Oncotarget (2016)

Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon

by Incorvaia, Lorena, Fanale, Daniele, Vincenzi, Bruno, De Luca, Ida, Bartolotta, Tommaso Vincenzo, Cannella, Roberto, Pantuso, Gianni, Cabibi, Daniela, Russo, Antonio, Bazan, Viviana, Badalamenti, Giuseppe
Published in Cancers (Basel) (2021)

Arterial Stiffness: Effects of Anticancer Drugs Used for Breast Cancer Women

by Novo, Giuseppina, Di Lisi, Daniela, Manganaro, Roberta, Manno, Girolamo, Lazzara, Simone, Immordino, Federico Angelo, Madaudo, Cristina, Carerj, Scipione, Russo, Antonio, Incorvaia, Lorena, Zito, Concetta
Published in Front Physiol (2021)

Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?

by Incorvaia, Lorena, Badalamenti, Giuseppe, Rinaldi, Gaetana, Iovanna, Juan Lucio, Olive, Daniel, Swayden, Mirna, Terruso, Lidia, Vincenzi, Bruno, Fulfaro, Fabio, Bazan, Viviana, Russo, Antonio, Fanale, Daniele
Published in Ther Adv Med Oncol (2019)

Impact of Chemotherapy in the Adjuvant Setting of Early Stage Uterine Leiomyosarcoma: A Systematic Review and Updated Meta-Analysis

by Rizzo, Alessandro, Nannini, Margherita, Astolfi, Annalisa, Indio, Valentina, De Iaco, Pierandrea, Perrone, Anna Myriam, De Leo, Antonio, Incorvaia, Lorena, Di Scioscio, Valerio, Pantaleo, Maria Abbondanza
Published in Cancers (Basel) (2020)

Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2

by Fanale, Daniele, Incorvaia, Lorena, Filorizzo, Clarissa, Bono, Marco, Fiorino, Alessia, Calò, Valentina, Brando, Chiara, Corsini, Lidia Rita, Barraco, Nadia, Badalamenti, Giuseppe, Russo, Antonio, Bazan, Viviana
Published in Cancers (Basel) (2020)

Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-...

by Fanale, Daniele, Incorvaia, Lorena, Badalamenti, Giuseppe, De Luca, Ida, Algeri, Laura, Bonasera, Annalisa, Corsini, Lidia Rita, Brando, Chiara, Russo, Antonio, Iovanna, Juan Lucio, Bazan, Viviana
Published in Cancers (Basel) (2021)

Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes

by Incorvaia, Lorena, Fanale, Daniele, Badalamenti, Giuseppe, Bono, Marco, Calò, Valentina, Cancelliere, Daniela, Castiglia, Marta, Fiorino, Alessia, Pivetti, Alessia, Barraco, Nadia, Cutaia, Sofia, Russo, Antonio, Bazan, Viviana
Published in Cancers (Basel) (2020)

Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients

by Passiglia, Francesco, Galvano, Antonio, Castiglia, Marta, Incorvaia, Lorena, Calò, Valentina, Listì, Angela, Mazzarisi, Salvatore, Perez, Alessandro, Gallina, Giuseppe, Rizzo, Sergio, Soto Parra, Hector, Bazan, Viviana, Russo, Antonio
Published in Ther Adv Med Oncol (2019)

Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)

by Incorvaia, Lorena, Fanale, Daniele, Badalamenti, Giuseppe, Barraco, Nadia, Bono, Marco, Corsini, Lidia Rita, Galvano, Antonio, Gristina, Valerio, Listì, Angela, Vieni, Salvatore, Gori, Stefania, Bazan, Viviana, Russo, Antonio
Published in Adv Ther (2019)

Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis

by Galvano, Antonio, Taverna, Simona, Badalamenti, Giuseppe, Incorvaia, Lorena, Castiglia, Marta, Barraco, Nadia, Passiglia, Francesco, Fulfaro, Fabio, Beretta, Giordano, Duro, Giovanni, Vincenzi, Bruno, Tagliaferri, Pierosandro, Bazan, Viviana, Russo, Antonio
Published in Ther Adv Med Oncol (2019)

Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for th...

by Incorvaia, Lorena, Fanale, Daniele, Badalamenti, Giuseppe, Porta, Camillo, Olive, Daniel, De Luca, Ida, Brando, Chiara, Rizzo, Mimma, Messina, Carlo, Rediti, Mattia, Russo, Antonio, Bazan, Viviana, Iovanna, Juan Lucio
Published in Oncoimmunology (2020)